Home  |  Contact

UniProtKB/Swiss-Prot O60939: Variant p.Asp211Gly

Sodium channel subunit beta-2
Gene: SCN2B
Chromosomal location: 11q23
Variant information

Variant position:  211
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Unclassified
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Aspartate (D) to Glycine (G) at position 211 (D211G, p.Asp211Gly).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and acidic (D) to glycine (G)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Note=Genetic variations in SCN2B may be involved in Brugada syndrome (PubMed:23559163). This tachyarrhythmia is characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:23559163}.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  Found in a patient with Brugada syndrome; unknown pathological significance; induces a reduction in sodium current density most likely by decreasing SCN5A protein cell surface expression.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  211
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  215
The length of the canonical sequence.

Location on the sequence:   LSTDDLKTEEEGKTDGEGNP  D DGAK
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LSTDDLKTEEEGKTDGEGNPDDGAK

                              LSTDDLKTEEEGKTDGEGNPDDGAK

Mouse                         LSTDDLKTEEEGKMDGEGNAEDGTK

Rat                           LSTDDLKTEEEGKTDGEGNAEDGAK

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 30 – 215 Sodium channel subunit beta-2
Topological domain 181 – 215 Cytoplasmic
Modified residue 192 – 192 Phosphoserine
Modified residue 204 – 204 Phosphothreonine


Literature citations

A missense mutation in the sodium channel beta2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome.
Riuro H.; Beltran-Alvarez P.; Tarradas A.; Selga E.; Campuzano O.; Verges M.; Pagans S.; Iglesias A.; Brugada J.; Brugada P.; Vazquez F.M.; Perez G.J.; Scornik F.S.; Brugada R.;
Hum. Mutat. 34:961-966(2013)
Cited for: VARIANT GLY-211; CHARACTERIZATION OF VARIANT GLY-211; POSSIBLE INVOLVEMENT IN BRUGADA SYNDROME;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.